跳至主要内容
临床试验/NCT02873169
NCT02873169已完成不适用

Interest of Implantable Cardioverter-defibrillator in Primary Prevention in Patient With Continuous Flow Left Ventricular Assist Device (CF-LVAD)

Rennes University Hospital20 个研究点 分布在 1 个国家目标入组 681 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
681
试验地点
20
主要终点
Occurrence of early VAs (<30 days post operatively) and late VAs (>30 days post operatively) in patient with CF-LVAD with or without ICD

研究概览

简要总结

Determination of risk factors of ventricular arrhythmias (VAs) after implantation of continuous flow left ventricular assist device in order to characterize which patient requires ICD implantation in primary prevention.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient above 18 years old
  • Patients with CF-LVAD with or without ICD

排除标准

  • Patients subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

结局指标

主要结局

Occurrence of early VAs (<30 days post operatively) and late VAs (>30 days post operatively) in patient with CF-LVAD with or without ICD

时间窗: 30 days

Clinical, biological, hemodynamic and rhythmic data

次要结局

  • Mortality in patients with CF-LVAD with or without VAs(30 days)
  • Mortality in patients with CF-LVAD with or without ICD(30 days)

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验